de Bruijn KM - Search Results

1

Is Navoban (tropisetron) as effective as Zofran (ondansetron) in cisplatin-induced emesis? The French Navoban Study Group.

Marty M, Kleisbauer JP, Fournel P, Vergnenegre A, Carles P, Loria-Kanza Y, Simonetta C, de Bruijn KM. Marty M, et al. Among authors: de bruijn km. Anticancer Drugs. 1995 Feb;6 Suppl 1:15-21. Anticancer Drugs. 1995. PMID: 7749165 Clinical Trial.

2

Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy: a randomized trial.

Adams M, Soukop M, Barley V, Yosef H, Anderson H, Boesen E, Trask CW, Rüfenacht E, de Bruijn KM. Adams M, et al. Among authors: de bruijn km. Anticancer Drugs. 1995 Aug;6(4):514-21. doi: 10.1097/00001813-199508000-00004. Anticancer Drugs. 1995. PMID: 7579555 Clinical Trial.

3

Tropisetron. A review of the clinical experience.

de Bruijn KM. de Bruijn KM. Drugs. 1992;43 Suppl 3:11-22. doi: 10.2165/00003495-199200433-00005. Drugs. 1992. PMID: 1380428 Review.

4

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.

Sorbe BG, Högberg T, Glimelius B, Schmidt M, Wernstedt L, Hansen O, Sörensen BT, Räisänen I, van Oosterom AT, de Bruijn KM. Sorbe BG, et al. Among authors: de bruijn km. Cancer. 1994 Jan 15;73(2):445-54. doi: 10.1002/1097-0142(19940115)73:2<445::aid-cncr2820730233>3.0.co;2-4. Cancer. 1994. PMID: 8293412 Clinical Trial.

5

Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.

Van Belle SJ, Stamatakis L, Bleiberg H, Cocquyt VF, Michel J, de Bruijn KM. Van Belle SJ, et al. Among authors: de bruijn km. Ann Oncol. 1994 Nov;5(9):821-5. doi: 10.1093/oxfordjournals.annonc.a059011. Ann Oncol. 1994. PMID: 7848884 Free article. Clinical Trial.

6

Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy.

Suarez A, Stettler ER, Rey E, Pons G, Simonetta-Chateauneuf C, de Bruijn KM, Olive G, Lemerle J. Suarez A, et al. Among authors: de bruijn km. Eur J Cancer. 1994;30A(10):1436-41. doi: 10.1016/0959-8049(94)00276-b. Eur J Cancer. 1994. PMID: 7833098 Clinical Trial.

7

Methodology of antiemetic trials.

McVie JG, de Bruijn KM. McVie JG, et al. Among authors: de bruijn km. Drugs. 1992;43 Suppl 3:1-5. doi: 10.2165/00003495-199200433-00003. Drugs. 1992. PMID: 1380427 Review.

8

Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy.

Sorbe B, Högberg T, Himmelmann A, Schmidt M, Räisänen I, Stockmeyer M, de Bruijn KM. Sorbe B, et al. Among authors: de bruijn km. Eur J Cancer. 1994;30A(5):629-34. doi: 10.1016/0959-8049(94)90534-7. Eur J Cancer. 1994. PMID: 8080678 Clinical Trial.

9

Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.

Schmidt M, Sorbe B, Högberg T, Himmelmann A, Räisänen I, Stockmeyer M, de Bruijn KM. Schmidt M, et al. Among authors: de bruijn km. Ann Oncol. 1993;4 Suppl 3:31-4. doi: 10.1093/annonc/4.suppl_3.s31. Ann Oncol. 1993. PMID: 8363997 Clinical Trial.

10

The development of tropisetron in its clinical perspective.

de Bruijn KM. de Bruijn KM. Ann Oncol. 1993;4 Suppl 3:19-23. doi: 10.1093/annonc/4.suppl_3.s19. Ann Oncol. 1993. PMID: 8363994 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters